Sort
48,018 grants matching “immunotherapy”
Development of a novel accurate therapy for multiple sclerosis
$403,826Gaddiel Galarza-Munoz · Autoimmunity Biologic Solutions, Inc. · R42 · FY2023 · AI
ShRNAmir-RV Library Construction and Production
$403,797Matthew Eugene Pipkin · La Jolla Institute For Immunology · U19 · FY2014 · AI
Multiple Approaches to Abeta Vaccination in Animal Models
$403,776David Hastings Cribbs · University Of California-Irvine · R01 · FY2007 · AG
T cell fate decisions and transplant outcomes
$403,750Xian Chang Li · Methodist Hospital Research Institute · R01 · FY2022 · AI
Identifying, Characterizing, and Targeting Regulators of B Cell Activation
$403,750Katherine Julia Susa · University Of California, San Francisco · DP5 · FY2025 · OD
T cell fate decisions and transplant outcomes
$403,750Xian Chang Li · Methodist Hospital Research Institute · R01 · FY2020 · AI
Immunoengineering Next-Generation Cancer Therapies with Focused Ultrasound
$403,750Natasha Diba Sheybani · University Of Virginia · DP5 · FY2022 · OD
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2025 · NS
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
$403,750Brian Barkley Graham · University Of California, San Francisco · R01 · FY2021 · HL
T cell fate decisions and transplant outcomes
$403,750Xian Chang Li · Methodist Hospital Research Institute · R01 · FY2021 · AI
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2023 · NS
Identifying, Characterizing, and Targeting Regulators of B Cell Activation
$403,750Katherine Julia Susa · University Of California, San Francisco · DP5 · FY2024 · OD
Immunoengineering Next-Generation Cancer Therapies with Focused Ultrasound
$403,750Natasha Diba Sheybani · University Of Virginia · DP5 · FY2021 · OD
T cell fate decisions and transplant outcomes
$403,750Xian Chang Li · Methodist Hospital Research Institute · R01 · FY2019 · AI
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2022 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$403,749Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2017 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$403,749Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2016 · NS
Using dietary glutamine supplementation for melanoma prevention and targeted therapy
$403,742Mei Kong · University Of California-Irvine · R01 · FY2024 · CA
Development
$403,724William L. Carroll · New York University School Of Medicine · P30 · FY2009 · CA
Research Training In Hematology
$403,714John Patrick Sheehan · University Of Wisconsin-Madison · T32 · FY2014 · HL
Develop universal CAR macrophage cell therapy for pancreatic cancer
$403,687Pingping Hou · Rutgers Biomedical And Health Sciences · R21 · FY2024 · CA
Phage-based therapeutic gene delivery targeting multiple compartments in solid tumors
$403,686Renata Pasqualini · Rutgers Biomedical And Health Sciences · R21 · FY2024 · CA
Sex specific epigenetic regulation of colon cancer metastasis
$403,649Y. Alan Wang · Indiana University Indianapolis · R01 · FY2022 · CA
Immune Aging in Responsiveness to Checkpoint Blockade Immunotherapies
$403,645Vandana Kalia · Seattle Children'S Hospital · R56 · FY2022 · AG
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
$403,612Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2020 · CA